Trial Profile
A Phase II Randomized, Placebo-Controlled, Double-Blinded Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve Calcification in Patients With Moderate Calcific Aortic Valve Stenosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ataciguat (Primary)
- Indications Aortic valve stenosis; Calcinosis
- Focus Therapeutic Use
- 14 Aug 2018 Status changed from active, no longer recruiting to completed.
- 20 Nov 2017 Planned primary completion date changed from 30 Sep 2017 to 1 Jun 2018.
- 08 May 2017 Planned End Date changed from 1 May 2017 to 1 Jul 2018.